| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2022 ( Subtotal = $243,911,062 ) (Continued on the next page) |
| | 2022 | 2022 | Vanderbilt University Medical Center | 1161 21st Ave S Ste D3300 MCN | Nashville | TN | 37232-0011 | DAVIDSON | USA | U1Q33085 | Geriatrics Workforce Enhancement Program | 00 | 4 | HRSA | 5/24/2022 | $186,238 |
| | 2022 | 2022 | Vanderbilt University Medical Center | 1161 21st Ave S Ste D3300 MCN | Nashville | TN | 37232-0011 | DAVIDSON | USA | U1Q33085 | Geriatrics Workforce Enhancement Program | 00 | 4 | HRSA | 5/24/2022 | $145,931 |
| | 2022 | 2022 | Vanderbilt University Medical Center | 1161 21st Ave S Ste D3300 MCN | Nashville | TN | 37232-0011 | DAVIDSON | USA | U1Q33085 | Geriatrics Workforce Enhancement Program | 00 | 4 | HRSA | 5/24/2022 | $394,379 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R21AI171466 | Genetic and immunological dissection of isolated Nocardiosis | 000 | 1 | NIH | 6/17/2022 | $216,250 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01AG073633 | Home-based cardiac rehabilitation using a novel mobile health exercise regimen following transcatheter heart valve interventions (HOME RUN HITTER) | 000 | 1 | NIH | 5/17/2022 | $751,297 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R21AI166870 | Loss of A-to-I editing stimulates SARS-CoV-2 anti-viral responses | 000 | 1 | NIH | 4/28/2022 | $259,500 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | K01HL161257 | Identifying molecular pathways in childhood asthma pathogenesis by integrating newborn metabolic profiles and GWAS data | 000 | 1 | NIH | 4/22/2022 | $129,798 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | K01HL161257 | Identifying molecular pathways in childhood asthma pathogenesis by integrating newborn metabolic profiles and GWAS data | 001 | 1 | NIH | 5/10/2022 | $0 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01DK129202 | Randomized Trial of Empiric Versus Selective Preventative Strategies for Kidney Stone Disease | 000 | 1 | NIH | 5/2/2022 | $349,814 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | K08DK132507 | Examining how the novel S64F MAFA variant produces glucose intolerance or hypoglycemia in a sex-dependent manner | 000 | 1 | NIH | 6/9/2022 | $158,316 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | U01CA262678 | Searching the blood metabolome to identify risk biomarkers for biliary tract cancer | 000 | 1 | NIH | 4/26/2022 | $692,641 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | F32CA268705 | Albumin-binding nanocomplexes for delivery of combination siRNA therapeutics to KRAS-driven cholangiocarcinoma | 000 | 1 | NIH | 6/9/2022 | $76,246 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01AI164587 | Nutritional immunity and microbial competition during Clostridioides difficile infection | 000 | 1 | NIH | 6/13/2022 | $470,532 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01HL164937 | Mechanisms of organ dysfunction and recovery in the Acetaminophen and Ascorbate Trial in Sepsis | 000 | 1 | NIH | 6/13/2022 | $445,056 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R35GM145375 | Oxygen and perioperative organ injury | 000 | 1 | NIH | 6/8/2022 | $432,500 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R21AI171901 | Impact of Pandemic Mitigation Efforts on Colonization and Transmission of Respiratory Pathogens and Antibiotic Resistance Genes | 000 | 1 | NIH | 6/8/2022 | $259,500 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | K25AG076864 | Development and Application of T1rho Dispersion Imaging of Aging Muscle | 000 | 1 | NIH | 5/26/2022 | $119,474 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01AG076785 | Common Inflammation Pathways between Aging and Hypertension That Weaken Bone | 000 | 1 | NIH | 5/5/2022 | $517,585 |
| | 2022 | 2022 | Vanderbilt University Medical Center | 1161 21st Ave S Ste D3300 MCN | Nashville | TN | 37232-0011 | DAVIDSON | USA | U01PS005240 | Implementation of Rapid HIV Testing and Linkage to HIV Treatment or Prevention Among Vulnerable Populations in Tennessee | 00 | 2 | CDC | 6/13/2022 | $1,358,764 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R21AR080914 | An inorganic polyphosphate-impregnated synthetic periosteum drives allograft osteointegration | 000 | 1 | NIH | 6/4/2022 | $245,974 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | K01EB032898 | Microstructure and connectivity modeling from the cortex to the spinal cord in Multiple Sclerosis | 000 | 1 | NIH | 5/27/2022 | $157,836 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01HL158918 | Roles of fibrin(ogen) in conformational activation of hemostatic proteinase precursors | 000 | 1 | NIH | 5/10/2022 | $495,738 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01HL161212 | Immune Modulation in Hypertension | 000 | 1 | NIH | 6/3/2022 | $634,453 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | P50HD106446 | Vanderbilt Integrated Center of Excellence in Maternal and Pediatric Precision Therapeutics (VICE-MPRINT) | 004 | 1 | NIH | 6/11/2022 | $593,248 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | P50HD106446 | Vanderbilt Integrated Center of Excellence in Maternal and Pediatric Precision Therapeutics (VICE-MPRINT) | 003 | 1 | NIH | 6/10/2022 | $394,591 |
| | 2022 | 2022 | BRIGHAM AND WOMEN'S HOSPITAL, INC., THE | 75 FRANCIS ST | BOSTON | MA | 02115-6110 | SUFFOLK | USA | K00CA245807 | Targeting the Epigenome to Improve Responses to Immunotherapy | 000 | 3 | NIH | 1/7/2022 | $93,312 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01DK126890 | Natriuretic peptide and cGMP signaling in adipose tissue and energy metabolism | 000 | 1 | NIH | 4/14/2022 | $506,890 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | F32AI169905 | Elucidating the mechanisms of antibiotic tolerance in Staphylococcus aureus biofilms | 001 | 1 | NIH | 5/25/2022 | $1,276 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | F32AI169905 | Elucidating the mechanisms of antibiotic tolerance in Staphylococcus aureus biofilms | 000 | 1 | NIH | 2/1/2022 | $70,458 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01HL163854 | Genetics and Triglycerides: opportunities for new approaches to identify therapies | 000 | 6 | NIH | 4/8/2022 | $819,698 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01HL160975 | Anion channel regulation of vascular superoxide signaling in hypertension | 000 | 1 | NIH | 6/10/2022 | $766,309 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R21AI164107 | Alu dsRNAs as adjuvants for influenza vaccines | 000 | 1 | NIH | 4/7/2022 | $228,562 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R21AR080372 | 2-HOBA Phase 2 Clinical Trial in Rheumatoid Arthritis | 000 | 1 | NIH | 4/15/2022 | $181,509 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | K23MH116339 | A translational approach to understand hippocampal neural circuitry regulating impulsive aggression | 001 | 6 | NIH | 3/21/2022 | $185,436 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01AR080629 | Predicting risk of systemic autoimmune disease in patients with positive antinuclear antibodies | 000 | 1 | NIH | 4/6/2022 | $400,690 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | K01AG077038 | Does Senescence Impair the Cardiovascular Benefits of Menopause Hormone Therapy? | 000 | 1 | NIH | 4/20/2022 | $120,177 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01DK132155 | Impact of Clonal Hematopoiesis on the Progression of Kidney Disease | 000 | 1 | NIH | 4/19/2022 | $740,540 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01HS028430 | Realtime Measurement of Situational Workload in NICU Nurses to Improve Workload Management and Patient Safety | 000 | 1 | AHRQ | 4/19/2022 | $399,932 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R21AI168832 | Esophageal Microbiome, Epithelial Gene Expression, and Response to Topical Swallowed Steroids in Pediatric Eosinophilic Esophagitis | 000 | 1 | NIH | 1/31/2022 | $259,500 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | D43TW012268 | Vanderbilt-Nigeria Biostatistics Training Program (VN-BioStat) | 001 | 1 | NIH | 3/31/2022 | -$50,000 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | D43TW012268 | Vanderbilt-Nigeria Biostatistics Training Program (VN-BioStat) | 001 | 1 | NIH | 3/31/2022 | $50,000 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | D43TW012268 | Vanderbilt-Nigeria Biostatistics Training Program (VN-BioStat) | 000 | 1 | NIH | 3/18/2022 | $299,500 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R37CA263614 | TCR signaling and cell cycle regulation in tumor-specific CD8 T cell dysfunction | 000 | 1 | NIH | 3/31/2022 | $580,177 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01NS121718 | Promoting Protein Trafficking with 4-phenylbutyrate to Treat Genetic Epilepsy | 000 | 1 | NIH | 2/24/2022 | $435,838 |
| | 2022 | 2022 | Vanderbilt University Medical Center | 1161 21st Ave S Ste D3300 MCN | Nashville | TN | 37232-0011 | DAVIDSON | USA | 90UCPH0056 | Expanding the Public Health Workforce within the Disability Network Program: University Centers for Excellence in Developmental Disabilities Education, Research, and Service (UCEDDs) | 00 | 1 | ACL | 4/1/2022 | $113,670 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R01DK132669 | Arginine regulation of alpha cell proliferation and function | 000 | 1 | NIH | 4/14/2022 | $420,170 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R03DK129559 | Creation and Testing of an Education Decision Aid for Colectomy in Recurrent Diverticulitis | 000 | 1 | NIH | 3/30/2022 | $129,750 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R21LM013807 | Data-Driven Guidance for Timing Repeated Inpatient Laboratory Tests | 000 | 1 | NIH | 3/31/2022 | $225,765 |
| | 2022 | 2022 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0011 | DAVIDSON | USA | R00HG010904 | A pipeline for identifying disease-causing variants in transmembrane proteins | 002 | 3 | NIH | 6/9/2022 | $6,120 |
|
